Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells

[1]  E. Underwood,et al.  A specific breeding problem of sheep on subterranean clover pastures in Western Australia. , 1946, The British veterinary journal.

[2]  G. S. Pope,et al.  The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. , 1966, The Journal of endocrinology.

[3]  G. S. Pope,et al.  Effect of norethisterone acetate, dimethylstilboestrol, genistein and coumestrol on uptake of [3H]oestradiol by uterus, vagina and skeletal muscle of immature mice. , 1969, The Journal of endocrinology.

[4]  A. Braden,et al.  Comparison of plasma phyto-oestrogen levels in sheep and cattle after feeding on fresh clover , 1971 .

[5]  H. Rochefort,et al.  Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues. , 1981, The Journal of biological chemistry.

[6]  H. Rochefort,et al.  Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. , 1982, Cancer research.

[7]  P. Darbre,et al.  Effect of estradiol on human breast cancer cells in culture. , 1983, Cancer research.

[8]  P. Darbre,et al.  Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. , 1984, Cancer research.

[9]  B. Rajanna,et al.  Influence of mercury on uptake of [3H]dopamine and [3H]norepinephrine by rat brain synaptosomes. , 1985, Toxicology letters.

[10]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[11]  R. Leake,et al.  Steroid Hormones: A Practical Approach , 1989 .

[12]  B. Luckow,et al.  CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements , 1987, Nucleic Acids Res..

[13]  J. T. Irwin,et al.  Interaction of phenol red with estrogenic and antiestrogenic action on growth of human breast cancer cells ZR-75-1 and T-47-D. , 1988, Cancer research.

[14]  R. Daly,et al.  Effects of oestrogen on human breast cancer cells in culture , 1989 .

[15]  R. Daly,et al.  Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells. , 1990, Cancer research.

[16]  M. Oishi,et al.  Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. , 1991, Cancer research.

[17]  C. Riccardi,et al.  Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. , 1994, European journal of cancer.

[18]  K. Korach,et al.  Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells. , 1994, Environmental health perspectives.

[19]  M. Waring,et al.  The Variable Metabolic Response to Dietary Isoflavones in Humans , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  S. Barnes,et al.  Genistein suppresses mammary cancer in rats. , 1995, Carcinogenesis.

[21]  C. Densmore,et al.  Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats. , 1995, Environmental health perspectives.

[22]  R. Mehta,et al.  Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. , 1996, Anticancer research.

[23]  Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. , 1996, Carcinogenesis.

[24]  S. Barnes,et al.  Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. , 1996, Carcinogenesis.

[25]  P. Darbre,et al.  3,4,3',4'-Tetrachlorobiphenyl acts as an estrogen in vitro and in vivo. , 1996, Molecular endocrinology.

[26]  Thomas T. Y. Wang,et al.  Molecular effects of genistein on estrogen receptor mediated pathways. , 1996, Carcinogenesis.

[27]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[28]  W. Mazur,et al.  Phyto-oestrogens and Western diseases. , 1997, Annals of medicine.

[29]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[30]  J. Jameson,et al.  Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Darbre,et al.  3,5,3′,5′-Tetrachlorobiphenyl is a weak oestrogen agonist in vitro and in vivo , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  Yu Chen Chang,et al.  Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. , 1997, The Journal of nutrition.

[33]  M. Kurzer,et al.  Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. , 1997, Nutrition and cancer.

[34]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[35]  M. Poutanen,et al.  Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[36]  S. Haslam,et al.  Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. , 1998, Cancer research.

[37]  S. Milligan,et al.  Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. , 1999, The Journal of clinical endocrinology and metabolism.

[38]  J. Ashby,et al.  Resveratrol and red wine consumption , 1999, Human & experimental toxicology.

[39]  W. Wahli,et al.  Structure and Function of the Estrogen Receptor , 1999 .

[40]  Z. Darżynkiewicz,et al.  Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. , 1999, International journal of oncology.

[41]  D. Crabb,et al.  Sensitivity of virally-driven luciferase reporter plasmids to members of the steroid/thyroid/retinoid family of nuclear receptors , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[42]  M. Oettel,et al.  Estrogens and Antiestrogens I , 2012, Handbook of Experimental Pharmacology.

[43]  H Fang,et al.  Quantitative comparisons of in vitro assays for estrogenic activities. , 2000, Environmental health perspectives.

[44]  L. Frémont.  Biological effects of resveratrol. , 2000, Life sciences.

[45]  L. Hilakivi-Clarke,et al.  Genistein: does it prevent or promote breast cancer? , 2000, Environmental health perspectives.

[46]  K Polkowski,et al.  Biological properties of genistein. A review of in vitro and in vivo data. , 2000, Acta poloniae pharmaceutica.

[47]  Assaying estrogenicity by quantitating the expression levels of endogenous estrogen-regulated genes. , 2000 .

[48]  T. Ishikawa,et al.  Identification of deoxymiroestrol as the actual rejuvenating principle of "Kwao Keur", Pueraria mirifica. The known miroestrol may be an artifact. , 2000, Journal of natural products.

[49]  H. Stopper,et al.  Genotoxicity of several clinically used topoisomerase II inhibitors. , 2000, Toxicology letters.

[50]  L Fioravanti,et al.  Genistein blocks breast cancer cells in the G2M phase of the cell cycle , 2000, Journal of cellular biochemistry.

[51]  H Fang,et al.  The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[52]  C. Klinge,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Resveratrol Acts as a Mixed Agonist/Antagonist for , 2022 .

[53]  W. Wünsche,et al.  Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[54]  M. A. Palma,et al.  Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. , 2000, The Journal of clinical endocrinology and metabolism.

[55]  J. Westendorf,et al.  Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. , 2001, Toxicology.

[56]  M. Mareel,et al.  8-Prenylnaringenin, the phytoestrogen in hops and beer, upregulates the function of the E-cadherin/catenin complex in human mammary carcinoma cells. , 2001, European journal of cell biology.

[57]  Y. Ju,et al.  Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. , 2001, Cancer research.

[58]  S. Andò,et al.  Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. , 2001, Molecular pharmacology.

[59]  N. Shikata,et al.  Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator , 2001, Journal of Cancer Research and Clinical Oncology.

[60]  S. Andò,et al.  Estrogen Receptor Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Two Major Phytoestrogens on Human Breast Cancer Cells , 2001 .

[61]  L. Howells,et al.  Differences between human breast cell lines in susceptibility towards growth inhibition by genistein , 2001, British Journal of Cancer.

[62]  H. Adlercreutz.  Can rye intake decrease risk of human breast cancer? , 2010, Food & nutrition research.

[63]  G. S. Pope,et al.  Oestrogenic activity of isobutylparaben in vitro and in vivo , 2002, Journal of applied toxicology : JAT.

[64]  G. S. Pope,et al.  Oestrogenic activity of parabens in MCF7 human breast cancer cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[65]  G. S. Pope,et al.  Oestrogenic activity of benzylparaben , 2003, Journal of applied toxicology : JAT.

[66]  G. Rechkemmer,et al.  Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. , 2003, Journal of agricultural and food chemistry.

[67]  Mengsu Yang,et al.  Inhibitory actions of genistein in human breast cancer (MCF-7) cells. , 2003, Biochimica et biophysica acta.

[68]  D. Kostelac,et al.  Phytoestrogens modulate binding response of estrogen receptors α and β to the estrogen response element , 2003 .

[69]  W. Gray,et al.  Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell. , 2003, Toxicology and applied pharmacology.

[70]  M. Hümpel,et al.  8‐prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo , 2004, Journal of cellular physiology.

[71]  C. Lamartiniere.  Timing of Exposure and Mammary Cancer Risk , 2004, Journal of Mammary Gland Biology and Neoplasia.

[72]  V. Speirs,et al.  Phyto-oestrogens and breast cancer chemoprevention , 2004, Breast Cancer Research.

[73]  L. Thompson,et al.  Ligand-Induced Regulation of ERα and ERβ is Indicative of Human Breast Cancer Cell Proliferation , 2003, Breast Cancer Research and Treatment.

[74]  Yiwei Li,et al.  Mechanisms of Cancer Chemoprevention by Soy Isoflavone Genistein , 2004, Cancer and Metastasis Reviews.

[75]  C. Osborne,et al.  Biological differences among MCF-7 human breast cancer cell lines from different laboratories , 2005, Breast Cancer Research and Treatment.